FSD201
FSD201-03
Phase 2 small_molecule terminated
Quick answer
FSD201 for COVID-19 is a Phase 2 program (small_molecule) at Quantum Biopharma with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Quantum Biopharma
- Indication
- COVID-19
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated